Jan 28, 2026 Episode Length: ~1215 minutes Target Audience: Pain physicians, anesthesiologists, PM&R, sports medicine, and regenerative medicine clinicians Hosted by: Dr
Hepatocyte growth factor prevents pulmonary ischemia-reperfusion injury in mice
As of 2026, cagrilintide is not FDA approved for any indication
This has also occurred in humans, such as iatrogenic Creutzfeld-Jakob disease (Brown et al., 2012), variant CJD in the context of bovine spongiform encephalopathy (Diack et al., 2014), Lewy body pathology spreading to transplanted fetal neurons (Li et al., 2008) and possibly even Alzheimers or cerebral amyloid pathology from injection with contaminated human growth hormone extracts (Purro et al., 2018